- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-18-0005918

About Sri Ambikare Pharma Private Limited
Data last updated:
Sri Ambikare Pharma Private Limited is a private limited company based in Mahbubnagar, Telangana, India, a subsidiary of Psn Medicare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC056228. Its GSTIN is 36AABCL3774C2ZN (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹3 Cr. It was formerly known as Leesa Lifesciences Private Limited. It is led by directors Kasthur Reddy Nemallapudi and Ramadevi Nemallapudi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at P2 Sy.No.423(P) 424(P) And 425(P) Jedcherla Mandal Polepally, Mahbubnagar, Telangana, India – 509203.
As per the financials filed for FY 2024, the company reported a revenue of ₹90.96 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.74 Lakh (net margin -3%) and EBITDA of -₹1.27 Lakh (EBITDA margin -1.4%).
As per MCA filings, the company has satisfied charges of ₹21.5 Cr on record. Court records list 27 cases involving the company, including 5 filed by the company and 22 filed against it; 4 cases are pending.
Sri Ambikare Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-18-0005918). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website leesalifesciences.com.
Company details
CIN history
Sri Ambikare Pharma has one previous CIN (Corporate Identification Number): U24232AP2007PTC056228. The current CIN is U24232TG2007PTC056228, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC056228 | Current |
| U24232AP2007PTC056228 | Previous |
Recognitions & Rankings of Sri Ambikare Pharma
Contact details
Sri Ambikare Pharma Private Limited's registered office is in Mahbubnagar, Telangana. Its website is leesalifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressP2 Sy.No.423(P) 424(P) And 425(P) Jedcherla Mandal Polepally, Mahbubnagar, Telangana, India – 509203
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sri Ambikare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sri Ambikare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sri Ambikare Pharma Private Limited, buy the company report.
Financials of Sri Ambikare Pharma Private Limited
FY 2024 filings availableSri Ambikare Pharma Private Limited reported revenue of ₹90.96 Lakh (up 189% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 189% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹90.96 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.4% | ||||
| Net Profit Margin | -3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sri Ambikare Pharma Private Limited, buy the company report.
Board of directors of Sri Ambikare Pharma Private Limited
Sri Ambikare Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kasthur Reddy Nemallapudi Also directs: PSN Medicare Private Limited | Director | 18 Oct 2022 | 4 Years 0 Months | Current |
| Ramadevi Nemallapudi Also directs: PSN Medicare Private Limited | Director | 18 Oct 2022 | 4 Years 0 Months | Current |
Auditor
Sri Ambikare Pharma Private Limited is audited by A.S.R.V. Prasad & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.S.R.V. Prasad & Co | FY 2024 | 009983S |
Shareholding
The shareholding of Sri Ambikare Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sri Ambikare Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Dec 2009 | 10188705 | State Bank of India | ₹21.5 Cr | Satisfied |
To see the full charge records of Sri Ambikare Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Sri Ambikare Pharma Private Limited has 27 court cases on record: 5 filed by Sri Ambikare Pharma, 22 filed against it. 4 cases are pending and 23 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 11 | 11 | 4 |
| High courts | 8 | 5 | 0 |
| District courts | 3 | 3 | 0 |
| Supreme Court | 3 | 3 | 0 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, Court I | Tribunal matter | Filed against the company by Everest Organics Limited | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Everest Organics Limited | Pending |
| NCLAT, Company Appeal(AT)(Ins) | Insolvency matter | Filed against the company by Everest Organics Ltd | Disposed |
| Supreme Court | Court case (1006-Company Law, Mrtp, Trai, Sebi, Idrai & Rbi : Others) | Filed against the company by Everest Organics Ltd. Rep. by Its Compliance Officer Rekha Singh Plot No. 127 and 128, Lakeview Plaza, 1St Floor, Amar Co Op Society, Near Kavuri Hills, Madhapur ,Hyderabad , Telangana | Disposed |
| NCLAT, Court I | Tribunal matter | Filed against the company by Everest Organics Limited | Disposed |
To see the full case history of Sri Ambikare Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sri Ambikare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sri Ambikare Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCL3774C2ZN | Telangana | Active | 01 Mar 2023 |
To see the full GST registrations and return filing status of Sri Ambikare Pharma Private Limited, buy the company report.
Recent activity
Sri Ambikare Pharma Private Limited has 7 board changes on record since 2008: 2 appointments and 5 cessations. The latest: Kasthur Reddy Nemallapudi was appointed as Director on 18 Oct 2022.
1 earlier event is in the company report.
Frequently asked questions
Sri Ambikare Pharma is an active private limited company based in Mahbubnagar, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 November 2007 (19+ years old) and is registered under CIN U24232TG2007PTC056228.
Sri Ambikare Pharma has 2 current directors:
- Kasthur Reddy Nemallapudi - Director
- Ramadevi Nemallapudi - Director
The latest financial statements of Sri Ambikare Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sri Ambikare Pharma is 36AABCL3774C2ZN, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Sri Ambikare Pharma is U24232TG2007PTC056228. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sri Ambikare Pharma has 27 court cases on record: 5 filed by the company and 22 filed against it. 4 are pending. Most are in the nclat.
Sri Ambikare Pharma was incorporated on 06 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
Kasthur Reddy Nemallapudi was appointed as Director on 18 Oct 2022. Ramadevi Nemallapudi was appointed as Director on 18 Oct 2022. Venkata Varaprasad Rao Gupta Kothuri ceased to be Director on 18 Oct 2022. Sri Ambikare Pharma has 7 board changes on record in total.
Yes, Sri Ambikare Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-18-0005918).
Sri Ambikare Pharma can be reached through the website leesalifesciences.com. Its registered office is in Mahbubnagar, Telangana, India.

